Leo Ehrlich

Chief Financial Officer, Innovation Pharmaceuticals Inc.

Companies

Innovation Pharmaceuticals Inc.Chair Jan 31, 2019 to Jan 4, 2023¹
Innovation Pharmaceuticals Inc.Chief executive officer Jul 30, 2012 to Jan 4, 2023²
Innovation Pharmaceuticals Inc.Board member Dec 15, 2008 to Aug 8, 2017³
Innovation Pharmaceuticals Inc.Chief financial officer Dec 15, 2008 to Dec 15, 2008³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Innovation Pharmaceuticals Inc.2,752,310 shares⁴Sep 28, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 28, 2020Shares withheld for tax 7,835,002 shares at $0.21 of Innovation Pharmaceuticals Inc.⁴
Feb 23, 2020Granted 500,000 shares of Innovation Pharmaceuticals Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInnovation Pharmaceuticals Inc., Chair
2
SEC EDGARInnovation Pharmaceuticals Inc., Chief executive officer
3
SEC EDGARInnovation Pharmaceuticals Inc., Board member
4
SEC EDGARInnovation Pharmaceuticals Inc. shares after the filing of Sep 28, 2022